Overview

Full Product Details

Author:   Paul A Bartlett (University of California at Berkeley, USA) ,  Michael Entzeroth ,  David M. J. Lilley ,  Marius Clore
Publisher:   Royal Society of Chemistry
Imprint:   Royal Society of Chemistry
Volume:   Volume 2
Dimensions:   Width: 15.60cm , Height: 2.90cm , Length: 23.40cm
Weight:   0.828kg
ISBN:  

9780854048427

ISBN 10:   0854048421
Pages:   444
Publication Date:   07 April 2006
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

"Part One: Operational Developments in Chemistry; Chapter 1: The Use of Polymer-assisted Solution-phase Synthesis and Automation for the High-throughput Preparation of Biologically Active Compounds; 1: Introduction; 2: PASP Synthesis Approaches to Biologically Active Compounds; 3: Automated PASP Synthesis of Biologically Active Molecules; 4: Flow Chemistry and Automation in the Synthesis of Drug-Like Molecules; 5: Conclusion; 6: References; Chapter 2: Accelerated Chemistry: Microwave, Sonochemical, and Fluorous Phase Techniques; 1: Introduction; 2: Microwave Enhanced Chemistry; 3: Sonochemistry as a Means to Accelerate Synthesis; 4: Fluorous Phase Techniques; 5: Conclusion; 6: References; Part Two: Conceptual Advances in Synthesis; Chapter 3: Biosynthesis of ""Unnatural"" Natural Products; 1: Introduction; 2: Type I Polyketide Synthases; 3: Type II Polyketide Synthases; 4: Type III Polyketide Synthase; 5: Conclusions; 6: Acknowledgements; 7: References; Chapter 4: Vombinatorial Synthetic Design: the Balance of Novelty and Familiarity; 1: Biological Macromolecules - Strength in Numbers; 2: Oligomer Synthesis - Improving on Mother Nature; 3: Random, Discovery, or Prospecting Libraries - the Quest for the Universal Scaffold; 4: Privileged Scaffolds - Look Where the Light is Brightest; 5: The Decoration or Synthesis of Novel Scaffolds - Aid for the Underprivileged; 6: Target Class Libraries - Diversity with a Purpose; 7: Peptide and Nucleotide Libraries Redux; 8: Lead Discovery or Drug Discovery - Size Does Matter; 9: Natural Product Scaffolds for Combinatorial Chemistry - Why Re-invent the Wheel?; 10: From Natural Products to Natural Product-like Libraries - Hubris or Progress?; 11: Lead Discovery and Combinatorial Chemistry - What Have we Learned?; 12: References; Chapter 5: Compound Collections: Acquisition, Annotation, and Access; 1: Introduction; 2: Commercial Offerings; 3: Companies Providing Non-proprietry, Non-parallel Synthesised Libraries (Shared-pool/""Collected Collections""); 4: Companies Providing In-house Designed, Parallel Synthesised Libraries; 5: Compound Selection and Database Filtering; 6: Substructure Similarity/Dissimilarity; 7: Pharmacophore Analysis; 8: Lipinski Rule-of-Five (LRoF); 9: Topological Polar Surface Area (tPSA) and Blood-Brain-Barrier Permeability (LogBB); 10: Solubility; 11: Examples of the Use of Chemical Annotation and Pharmacophore based lead-hopping; 12: Compound Acquisition; 13: References; Chapter 6: Chemical Diversity: Definition and Quantification; 1: Introduction; 2: Diversity Metrics; 3: Molecular Description; 4: Dimensionality Reduction; 5: Subset Selection and Classification; 6: Conclusion; 7: Abbreviations; 8: References; Part Three: Mining: Turning a Hit into a Lead; Chapter 7: Focused Libraries: the Evolution in Strategy from Large Diversity Libraries to the Focused Library Approach; 1: Introduction; 2: A Synergistic, Multidisciplinary Approach to Library Conception; 3: Library Design Concepts; 4: Focused libraries; 5: Summary; 6: References; Chapter 8:Translating Peptides into Small Molecules; 1: Peptides as Drugs: The Good, the Bad and the Ugly; 2: Origin of Biologically Active Peptides; 3: General Strategy for Translating Peptides into Small Molecules; 4: Tailoring Peptide Sequences for Their Translation into Small Molecules; 5: Transformation of peptide Ligands into Small Molecules Using Computational Approaches; 6: References; Part Four: Operational Developments in Screening; Chapter 9: High Density Plates, Microarrays, Microfluidics; 1: Functional High-density Well Plates for High-throughput Assays; 2: Parallel Liquid Handling of Low-volume Samples; 3: Microarray Assays on Chips; 4: Prospects for Multi-Parameter Assays; 5: References; Chapter 10: Fluorescence Technologies for the Investigation of Chemical Libraries; 1: Introduction; 2: Dissociation Enhanced Lanthanide Fluoroimmunoassay (DELFIA); 3: Enzyme Fragment Complementation (EFC); 4: Fluorescence Polarization (FP); 5: Fluorescence Correlation Spectroscopy (FCS); 6: Amplified Luminescent Proximity Homogeneous Assay (Alphascreen); 7: Fluorescence Resonance Energy Transfer (FRET); 8: Bioluminescence Resonance Energy Transfer (BRET); 9: Homogeneous Time Resolved Fluorescence (HTRF); 10: Conclusion; 11: References; Chapter 11: The Use of Genetically Engineered Cell-based Assays in in-vitro Drug Discovery; 1: Introduction; 2: Genetic Engineering for Cell-based Assays; 3: Reporter-based Assays; 4: Assays to Measure Intracellular Calcium; 5: Assays to Monitor Protein-Protein Interactions; 6: Conclusions and Outlook; 7: References; Chapter 12: NMR Based Screening, a Powerful Tool in Fragment-based Drug Discovery; 1: Introduction; 2: NMR Screening: General Aspects; 3: Ligand- vs Traget-detected Methods; 4: Incorporation of NMR into the Drug Discovery Process; 5: Representative Case Studies; 6: Conclusion; 7: References; Chapter 13: Screening Chemical Microarrays: Methods and Applications; 1: Introduction; 2: Screening of Chemical Microarrays; 3: Applications of Chemical Microarrays; 4: Conclusion; 5: References; Part Five: Conceptual Advances in Lead Evaluation; Chapter 14: Screen/Counter-screen: Early Assessment of Selectivity; 1: Introduction; 2: Approaches Used for Selection of Drug Candidates; 3: Summary; 4: References; Chapter 15: Concepts for in-vitro Profiling - Drug Activity, Selectivity and Liability; 1: Introduction; 2: Physico Chemical Parameters; 3: Permeability; 4: Metabolism; 5: Protein Binding; 6: Toxicity; 7: Investigation of Compound Selectivity; 8: Conclusion and Outlook; 9: Reference; Chapter 16: In silico Surrogates for in vivo Properties: Profiling for ADME and Toxicological Behavior; 1: In silico Surrogates for in vivo Properties; 2: Estimation of Biopharmaceutical Properties; 3: Estimation of Pharmacokinetic Properties; 4: Estimation of Toxicological Properties; 5: Integration of Surrogate Data and Estimations with Physiological Simulation; 6: References; Chapter 17: Use of High Content Screening in Chemical Optimization; 1: Introduction; 2: HCS Systems; 3: Examples Show the Power of HCS; 4: Summary"

Reviews

...a timely and comprehensive overview of state-of-the-art developments in the diverse scientific and engineering disciplines...thoughtful preface...helpful and refreshing. Is an excellent and astonishingly complete compilation on this broad and demanding topic for current practitioners. Researchers in organic and medicinal chemistry, and in biological and pharmacological sciences, as well as those interested in allied computational and engineering disciplines, will benefit from the up-to-date coverage. High quality of the individual chapters. -- Angewandte Chemie, International Edition, 2007, 46, 22 (Andreas Link) Angewandte Chemie, International Edition Each chapter contains a comprehensive and up-to-date list of references as recent as 2005. An excellent introduction to evolving methodologies in the drug discovery process...excellent overview for medicinal chemists and all others involved in the drug discovery process. -- Journal of Medicinal Chemistry, 2007, Vol.50, No.2 (Carl Kaiser) Journal of Medicinal Chemistry Excellent review articles covering advances in synthesis and screening, while providing a roadmap for how science meets technology to generate unique and diverse starting points for projects in drug discovery. Well organised and balanced between a high-level overview of lead identification and detailed descriptions of technologies...a strong framework for understanding how all of the pieces can fit together in the modern pharmaceutical endeavor...are written clearly and with a sufficient level of detail so that those working in technology-focused groups will find them meaningful. The book reduces a very complex area of drug discovery into meaningful categories and provides orientation to scientists confronted by the broad range of options in lead discovery. -- Journal of the American Chemical Society, Vol.128, No.51, 2006 (Terence A Kelly) Journal of the American Chemical Society

....a timely and comprehensive overview of state-of-the-art developments in the diverse scientific and engineering disciplines...thoughtful preface.....helpful and refreshing.Is an excellent and astonishingly complete compilation on this broad and demanding topic for current practitioners. Researchers in organic and medicinal chemistry, and in biological and pharmacological sciences, as well as those interested in allied computational and engineering disciplines, will benefit from the up-to-date coverage. High quality of the individual chapters. * Angewandte Chemie, International Edition, 2007, 46, 22 (Andreas Link) * Each chapter contains a comprehensive and up-to-date list of references as recent as 2005.An excellent introduction to evolving methodologies in the drug discovery process.....excellent overview for medicinal chemists and all others involved in the drug discovery process. * Journal of Medicinal Chemistry, 2007, Vol.50, No.2 (Carl Kaiser) * Excellent review articles covering advances in synthesis and screening, while providing a roadmap for how science meets technology to generate unique and diverse starting points for projects in drug discovery.Well organised and balanced between a high-level overview of lead identification and detailed descriptions of technologies.....a strong framework for understanding how all of the pieces can fit together in the modern pharmaceutical endeavor.....are written clearly and with a sufficient level of detail so that those working in technology-focused groups will find them meaningful.The book reduces a very complex area of drug discovery into meaningful categories and provides orientation to scientists confronted by the broad range of options in lead discovery. * Journal of the American Chemical Society, Vol.128, No.51, 2006 (Terence A Kelly) *

....a timely and comprehensive overview of state-of-the-art developments in the diverse scientific and engineering disciplines...thoughtful preface.....helpful and refreshing.Is an excellent and astonishingly complete compilation on this broad and demanding topic for current practitioners. Researchers in organic and medicinal chemistry, and in biological and pharmacological sciences, as well as those interested in allied computational and engineering disciplines, will benefit from the up-to-date coverage. High quality of the individual chapters. * Angewandte Chemie, International Edition, 2007, 46, 22 (Andreas Link) * Each chapter contains a comprehensive and up-to-date list of references as recent as 2005.An excellent introduction to evolving methodologies in the drug discovery process.....excellent overview for medicinal chemists and all others involved in the drug discovery process. * Journal of Medicinal Chemistry, 2007, Vol.50, No.2 (Carl Kaiser) * Excellent review articles covering advances in synthesis and screening, while providing a roadmap for how science meets technology to generate unique and diverse starting points for projects in drug discovery.Well organised and balanced between a high-level overview of lead identification and detailed descriptions of technologies.....a strong framework for understanding how all of the pieces can fit together in the modern pharmaceutical endeavor.....are written clearly and with a sufficient level of detail so that those working in technology-focused groups will find them meaningful.The book reduces a very complex area of drug discovery into meaningful categories and provides orientation to scientists confronted by the broad range of options in lead discovery. * Journal of the American Chemical Society, Vol.128, No.51, 2006 (Terence A Kelly) *

...a timely and comprehensive overview of state-of-the-art developments in the diverse scientific and engineering disciplines...thoughtful preface...helpful and refreshing. Is an excellent and astonishingly complete compilation on this broad and demanding topic for current practitioners. Researchers in organic and medicinal chemistry, and in biological and pharmacological sciences, as well as those interested in allied computational and engineering disciplines, will benefit from the up-to-date coverage. High quality of the individual chapters. -- Angewandte Chemie, International Edition, 2007, 46, 22 (Andreas Link) Angewandte Chemie, International Edition Each chapter contains a comprehensive and up-to-date list of references as recent as 2005. An excellent introduction to evolving methodologies in the drug discovery process...excellent overview for medicinal chemists and all others involved in the drug discovery process. -- Journal of Medicinal Chemistry, 2007, Vol.50, No.2 (Carl Kaiser) Journal of Medicinal Chemistry Excellent review articles covering advances in synthesis and screening, while providing a roadmap for how science meets technology to generate unique and diverse starting points for projects in drug discovery. Well organised and balanced between a high-level overview of lead identification and detailed descriptions of technologies...a strong framework for understanding how all of the pieces can fit together in the modern pharmaceutical endeavor...are written clearly and with a sufficient level of detail so that those working in technology-focused groups will find them meaningful. The book reduces a very complex area of drug discovery into meaningful categories and provides orientation to scientists confronted by the broad range of options in lead discovery. -- Journal of the American Chemical Society, Vol.128, No.51, 2006 (Terence A Kelly) Journal of the American Chemical Society (JACS) ...a timely and comprehensive overview of state-of-the-art developments in the diverse scientific and engineering disciplines...thoughtful preface...helpful and refreshing. Is an excellent and astonishingly complete compilation on this broad and demanding topic for current practitioners. Researchers in organic and medicinal chemistry, and in biological and pharmacological sciences, as well as those interested in allied computational and engineering disciplines, will benefit from the up-to-date coverage. High quality of the individual chapters. Each chapter contains a comprehensive and up-to-date list of references as recent as 2005. An excellent introduction to evolving methodologies in the drug discovery process...excellent overview for medicinal chemists and all others involved in the drug discovery process. Excellent review articles covering advances in synthesis and screening, while providing a roadmap for how science meets technology to generate unique and diverse starting points for projects in drug discovery. Well organised and balanced between a high-level overview of lead identification and detailed descriptions of technologies...a strong framework for understanding how all of the pieces can fit together in the modern pharmaceutical endeavor...are written clearly and with a sufficient level of detail so that those working in technology-focused groups will find them meaningful. The book reduces a very complex area of drug discovery into meaningful categories and provides orientation to scientists confronted by the broad range of options in lead discovery.

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions